At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
PX0612 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome: A Randomized, Double-Blind Placebo Controlled Clinical Trial
In Brief
A clinical study evaluating PX0612 and Di-Calcium Phosphate for Irritable Bowel Syndrome With Diarrhea. Completed, enrolled 50 participants across 1 site.
Detailed Summary
IBS is a disorder of movement in the gut. People who have IBS may have diarrhea, constipation, or alternating bouts of both. IBS is not caused by injury or illness. Often the only way doctors can diagnose it is to rule out other conditions through testing.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIrritable Bowel Syndrome With Diarrhea
CountriesCanada
CollaboratorsUniversity of Alberta
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 2015
Enrollment StartJan 2016
Primary CompletionAug 2018
TodayJul 2026
First PostedMay 1, 2015
Enrollment StartJan 1, 2016
Primary CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 11.2 years ago
Interventions
PX0612dietary
PX0612 is a probiotic contained in a veggie capsule.
Di-Calcium Phosphatedietary
Patients in the 'placebo' group will receive the placebo capsules. The main ingredient in the placebo capsule is Di-Calcium Phosphate